GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Price-to-Owner-Earnings

Lumos Diagnostics Holdings (ASX:LDX) Price-to-Owner-Earnings : (As of Jun. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Price-to-Owner-Earnings?

As of today (2024-06-15), Lumos Diagnostics Holdings's share price is A$0.033. Lumos Diagnostics Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Lumos Diagnostics Holdings's Price-to-Owner-Earnings or its related term are showing as below:


ASX:LDX's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.1
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-15), Lumos Diagnostics Holdings's share price is A$0.033. Lumos Diagnostics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03. Therefore, Lumos Diagnostics Holdings's PE Ratio for today is At Loss.

As of today (2024-06-15), Lumos Diagnostics Holdings's share price is A$0.033. Lumos Diagnostics Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was A$-0.03. Therefore, Lumos Diagnostics Holdings's PE Ratio without NRI for today is At Loss.


Lumos Diagnostics Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Lumos Diagnostics Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Price-to-Owner-Earnings Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23
Price-to-Owner-Earnings
- -

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Lumos Diagnostics Holdings's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Diagnostics Holdings's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Price-to-Owner-Earnings falls into.



Lumos Diagnostics Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Lumos Diagnostics Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.033/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings  (ASX:LDX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Lumos Diagnostics Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Diagnostics Holdings (ASX:LDX) Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines